Xin Lang Cai Jing·2026-03-03 07:19Group 1 - Kailaiying's stock price has dropped 2.05% to 92.50 CNY per share, with a total market capitalization of 33.381 billion CNY, and a cumulative decline of 7.07% over the last four days [1] - The company, established on October 7, 1998, and listed on November 18, 2016, primarily provides CMO pharmaceutical outsourcing services, with revenue composition of 76.19% from small molecule CDMO solutions, 23.71% from emerging services, and 0.10% from other sources [1] Group 2 - Morgan Fund holds 3,500 shares of Kailaiying in its Morgan Antong Return Mixed A fund, representing 1.24% of the fund's net value, ranking as the fifth largest holding [2] - The fund has experienced a floating loss of approximately 6,790 CNY today and a total floating loss of 24,600 CNY during the four-day decline [2] - Morgan Antong Return Mixed A fund, established on April 26, 2017, has a total scale of 13.6117 million CNY, with a year-to-date return of 2.8% and a one-year return of 13.85% [2]